|
US2018264080A1
|
|
TOPICAL APPLICATIONS OF Kv1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION
|
|
WO2015100370A2
|
|
Sustained release depot formulations of therapeutic proteins, and uses thereof
|
|
CN105407904A
|
|
Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof
|
|
WO2014138245A2
|
|
Methods of treating ipex syndrome using toxin-based pharmaceutical compositions
|
|
US2015072940A1
|
|
Treatment of Obesity and Obesity-Related Disorders by Pharmalogical Targeting of Kv 1.3 Potassium Channels
|
|
CA2838474A1
|
|
Shk-based pharmaceutical compositions and methods of manufacturing and using the same
|
